Table 4.
Terlipressin (n = 56)
|
Placebo (n = 56)
|
|||||
---|---|---|---|---|---|---|
n | % | 95% CI | n | % | 95% CI | |
Received concomitant beta-blockers | ||||||
HRS reversal | 8/16 | 50 | 25–75 | 2/23 | 9 | 1–28 |
180-day survival estimate | - | 56 | - | - | 35 | - |
| ||||||
Did not receive concomitant beta-blockers | ||||||
HRS reversal | 11/40 | 28 | 15–44 | 5/33 | 15 | 5–32 |
180-day survival estimate | - | 38 | - | - | 39 | - |
95% CI: 95% confidence intervals.